ArticleEClinicalMedicine2025
Examining the feasibility of a crisis-focused Cognitive Behaviour Therapy (CBT)-informed psychological intervention for inpatients experiencing psychosis (the CRISIS study): results from a pilot randomised controlled trial.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cognitive Behavioural Therapy for psychosis (CBTp) is a psychological intervention that should be offered in the acute phase of psychosis. However, there is little evidence to guide its delivery. The aim of this study was to examine the feasibility of a randomised controlled trial (RCT) of a crisis-focused CBTp-informed intervention (cCBTp) with inpatients. The intervention was co-produced with a stakeholder group. Methods: Participants were included if they were experiencing psychosis and receiving care from a psychiatric inpatient service at the time of consent. We aimed to recruit n = 60 inpatients and randomise them on a 1:1 ratio to either receive cCBTp plus treatment as usual (TAU) or TAU alone. Follow-ups were conducted at 2, 6, and 12 months. An average of 6-8 sessions of the intervention were offered. The primary objective was to examine indicators of feasibility (recruitment, data collection rates, intervention delivery). The study was prospectively registered (ISRCTN59055607) and is now complete. Findings: Between 1st February 2021 and 28th February 2022, 145 participants were referred to the study and 52 participants were randomised (during the COVID-19 pandemic). 26 were randomly allocated to cCBTp and 26 to TAU. We were able to recruit 87% of our target sample size. The face-to-face data collection rate (measures of symptoms, recovery, quality of life and service use) was 58% at 2 months and 60% at 6 months, which was below the proposed feasibility threshold. Collection of Electronic Health Record (EHR) data (relapse, rehospitalisation, and adverse events) was at 86% at 6 months and 83% at 12 months. Nine (35%) participants in the cCBTp arm and n = 7 (27%) in the TAU arm had an adverse or serious adverse event. None were assessed as related to participation in the intervention or the trial. Interpretation: This study demonstrated that a pilot RCT of cCBTp was feasible with inpatients experiencing psychosis. A further large-scale fully powered trial is required to evaluate its effectiveness and cost-effectiveness, including modified strategies for follow-up data collection. Funding: This research was funded by the National Institute of Health Research (ICA-CL-2018-04-ST2-013).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.